videos
Discovery to Commercialization: A New Immunotherapy for Rare Childhood Cancer, Neuroblastoma
Donna L. Bialozor, AACP, Malcolm Smith, M.D., Ph.D., Samir H. Shaban, M.S., Beverly G. Keseling, B.S., and Alice Yu, M.D., Ph.D., discuss the National Cancer Institute's Neuroblastoma technology which received a 2016 FLC Excellence in Technology Transfer award.